Study at a glance
How might vitamin D affect the release of iron from cells?
This page summarises laboratory and human evidence about vitamin D and the release of iron from cells. Hepcidin reduces iron release by acting on ferroportin, the protein that lets iron leave cells. Lower hepcidin may make iron more available in the blood even when the total amount of iron stored in the body has not changed.
What did laboratory experiments show about vitamin D and iron release?
In liver and immune cells grown in the laboratory, vitamin D reduced activity of the gene that makes hepcidin. Further experiments supported a direct effect through the vitamin D receptor, which receives vitamin D signals inside cells. Ferroportin protein increased as activity of the hepcidin gene decreased. This supports a way for vitamin D to influence iron release.
How did vitamin D affect hepcidin in people?
In a small experiment, a single 100,000 IU dose of vitamin D2 was followed by about 34% lower blood hepcidin within 24 hours. A later trial randomly assigned 28 healthy adults to a single 250,000 IU dose of vitamin D3 or an inactive treatment. After one week, hepcidin had fallen about 73% from its starting value in the vitamin D group. The comparison group did not show a significant reduction. These were research doses, not instructions for personal use.
Does lower hepcidin mean anaemia has been corrected?
Ferritin, a measure related to iron stores, and measured inflammation signals did not change significantly in the later trial. Lower hepcidin does not guarantee correction of anaemia. Producing haemoglobin, the oxygen-carrying substance in red blood cells, also depends on iron stores, kidney and bone-marrow function, inflammation and other nutrients. The evidence does not support replacing diagnosis or treatment of iron deficiency or anaemia with vitamin D.
Read the full article below ↓Hepcidin determines how readily iron can leave intestinal cells and macrophages and become available in the circulation. Vitamin D signalling can interact directly with this regulatory system. Experimental evidence shows suppression of the hepcidin gene HAMP through vitamin-D-receptor-related transcriptional mechanisms, while human supplementation studies show rapid falls in circulating hepcidin after high-dose vitamin D exposure. This creates a specific mechanistic connection with Vitamin D and Iron Metabolism. For the detailed evidence review, see Vitamin D Regulation of Hepcidin, Ferroportin and Iron Mobilisation: Full Study.
Why hepcidin matters
Hepcidin binds to ferroportin, the major cellular iron exporter. Increased hepcidin reduces iron release from intestinal cells and iron-recycling macrophages. Lower hepcidin permits greater potential iron export. This means circulating iron availability can change even when total iron stores have not changed.
Inflammation can raise hepcidin and contribute to functional iron restriction, which connects this pathway with Vitamin D and Inflammatory Signalling.
Vitamin D can suppress the hepcidin gene
Bacchetta and colleagues found that 25(OH)D and 1,25(OH)₂D reduced HAMP messenger RNA in cultured hepatocytes and monocytes. Promoter and chromatin experiments supported direct transcriptional regulation through vitamin D receptor signalling. Reduced HAMP expression was accompanied by increased ferroportin protein.
In a small human experiment, a single 100,000 IU dose of vitamin D₂ increased circulating 25(OH)D and was followed by an approximately 34% fall in hepcidin within 24 hours.
Randomized evidence reproduced the hepcidin effect
A subsequent randomized placebo-controlled trial in 28 healthy adults used a single 250,000 IU dose of vitamin D₃. Hepcidin fell by approximately 73% from baseline after one week in the vitamin-D group, while the placebo group did not show a significant reduction.
Ferritin and measured inflammatory cytokines did not change significantly. The result therefore supports an effect on hepcidin that cannot be explained simply by rapid depletion of iron stores or by a measurable general reduction in those cytokines.
A hepcidin response is not the same as correcting anaemia
Lowering hepcidin may increase the physiological opportunity for iron mobilisation, but haemoglobin production depends on iron stores, erythropoietin, bone-marrow function, renal physiology, inflammation and other nutrients. A molecular effect therefore does not guarantee a whole-body clinical result.
This is one example of the broader distinction described in Vitamin D Status vs Vitamin D Effect. It also explains why later trials in chronic disease can produce different results despite a credible mechanism.
The strongest conclusion is that vitamin D can participate in regulation of the hepcidin-ferroportin axis. It is not evidence that vitamin D supplementation should replace diagnosis or treatment of iron deficiency or anaemia.
Scientific sources
Adriana Bacchetta and colleagues. Suppression of iron-regulatory hepcidin by vitamin D. PMID: 24204002.
Jessica A Alvarez and colleagues. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults. PMID: 27402475.
Related reading
Vitamin D Regulation of Hepcidin, Ferroportin and Iron Mobilisation: Full Study
Human and mechanistic evidence showing how vitamin D can suppress hepcidin, alter ferroportin regulation and influence iron mobilisation.
Read more →Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation
Markers of the renal-bone axis, inflammation and iron status were investigated pre: and post-supplementation.
Original paper ↗Read more →High ferritin is associated with liver and bone marrow iron accumulation: Effects of 1-year deferoxamine treatment in hemodialysis-associated iron overload
Iron (Fe) supplementation is a critical component of anemia therapy for patients with chronic kidney disease (CKD).
Original paper ↗Read more →Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections
The aim of this prospective clinical study is to evaluate the association of i-FGF23 with hepcidin and markers of iron homeostasis, erythropoiesis, inflammation, and bone mineral metabolism in acute pediatric infections.
Original paper ↗Read more →The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom
Our aim was to identify whether antenatal vitamin D3 supplementation affects iron status (via hepcidin suppression) and/or inflammation.
Original paper ↗Read more →1,25(OH)2D3 Inhibited Ferroptosis in Zebrafish Liver Cells (ZFL) by Regulating Keap1-Nrf2-GPx4 and NF-κB-hepcidin Axis
Ferroptosis is a kind of iron-dependent programed cell death.
Original paper ↗Read more →Effects of a second iron-dextran injection administered to piglets during lactation on differential gene expression in liver and duodenum at weaning
Six female littermate piglets were used in an experiment to evaluate the mRNA expression in tissues from piglets given one or two 1 mL injections of iron dextran (200 mg Fe/mL).
Original paper ↗Read more →Multiple Indicators of Undernutrition, Infection, and Inflammation in Lactating Women Are Associated with Maternal Iron Status and Infant Anthropometry in Panama: The MINDI Cohort
Maternal infections, nutrient deficiencies, and inflammation (MINDI) co-exist in lactating indigenous women in Panama, but their impact on maternal iron status and infant growth is unknown.
Original paper ↗Read more →Multiple Infections, Nutrient Deficiencies, and Inflammation as Determinants of Anemia and Iron Status during Pregnancy: The MINDI Cohort
In pregnant women with multiple infections, nutrient deficiencies, and inflammation (MINDI), the study of anemia and iron status is limited.
Original paper ↗Read more →The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
We evaluated the change in markers of hepcidin expression, erythropoiesis, and iron status from baseline to week 12 and compared the change between the groups.
Original paper ↗Read more →Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Full Study
Evidence linking vitamin D status with inflammation, hepcidin, iron restriction and haemoglobin in inflammatory disease.
Read more →Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Study Summary
A concise review of vitamin D, inflammatory hepcidin signalling, iron restriction and anaemia-related physiology.
Read more →A comparative study of the injury patterns and inflammatory response between suicidal and unintentional falls from height in Germany
This study aims to analyse injury patterns, inflammatory responses and complication rates in people who have jumped to their death, compared to those who have fallen unintentionally.
Original paper ↗Read more →An Inflammation-Adjusted Framework for Nutritional Assessment in Multimorbid Patients with Advanced Neurological Diseases
Background and Objectives: Laboratory parameters associated with nutritional and metabolic status may be substantially influenced by inflammatory activity, complicating their interpretation in patients with advanced neurological diseases.
Original paper ↗Read more →Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy: A Hospital-Based Prospective Observational Study
Background: Negative outcomes associated with medications (NOM) and drug-related problems (DRP) significantly impact individuals with kidney replacement therapy (KRT) given the complexities of managing kidney disease and associated comorbidities.
Original paper ↗Read more →Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Vitamin D Genetics Beyond Serum 25(OH)D: VDR rs2228570 (FokI) Polymorphism, Inflammation, and Quality of Life in Orthopedic Patients
This study investigated the rs2228570 (FokI) variant in relation to inflammatory, hematologic, and patient-reported outcomes in orthopedic patients.
Original paper ↗Read more →Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus
In the recessive model, the genotype ApaI AA was found more frequently among HCC compared to CHB patients (OR = 2.56, 95%CI = 1.01 to 6.48, P = 0.04).
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Original sources
Suppression of iron-regulatory hepcidin by vitamin D
Adriana Bacchetta and colleagues.
Publication details
Adriana Bacchetta and colleagues. Suppression of iron-regulatory hepcidin by vitamin D. PMID: 24204002.
High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults
Jessica A Alvarez and colleagues.
Publication details
Jessica A Alvarez and colleagues. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults. PMID: 27402475.